Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Jul 11;5(2):207-11.
doi: 10.1159/000365442. eCollection 2014 May.

Hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy

Aditya Kelkar  1 , Poonam Gandhi  1 , Winfried Amoaku  2 , Jai Kelkar  1 , Shreekant Kelkar  1 , Priyanka Raut  1 , Rachana Shah  1
Affiliations
Case Reports

Hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy

Aditya Kelkar et al. Case Rep Ophthalmol. .

Abstract

We hereby report a case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy (CSC). Issues regarding safety and adverse effects of bevacizumab are discussed. To the best of our knowledge, this is the first reported case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal CSC.

Keywords: Central serous chorioretinopathy; Hemorrhagic macular infarction; Intravitreal bevacizumab.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Right-eye fundus preinjection showing pigmentary changes at the fovea with blunted foveal reflex. Right-eye OCT: shallow RPE elevation with reflectivity under the RPE layer suggestive of nonserous PED, along with minimal subretinal fluid. Right-eye fluorescein angiography preinjection: mottled hyperfluorescence of 2.5-mm disc diameters.
Fig. 2
Fig. 2
Right-eye fundus 1 month postinjection showing multiple hemorrhages, PED and extensive hard exudates at the macula, inferior to the arcade as well as nasal to the disc. OCT: increase in sensory detachment with fluid accumulation in the sensory retina. Fluorescein angiography: areas of capillary nonperfusion with adjacent mottled hyperfluorescence.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Gilbert CM, Owens SL, Smith PD, Fine SL. Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol. 1984;68:815–820. - PMC - PubMed
    1. Huang WC, Chen WL, Tsai YY, Chiang CC, Lin JM. Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eye. 2009;23:488–489. - PubMed
    1. Iida T, Yannuzzi LA, Spaide RF, et al. Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina. 2003;23:1–7. - PubMed
    1. Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol Scand. 2008;86:126–145. - PubMed
    1. Schaal KB, Hoeh AE, Scheuerle A, Schuett F, Dithmar S. Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eur J Ophthalmol. 2009;19:613–617. - PubMed

Publication types

LinkOut - more resources